Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling

BACKGROUND Recent improvements in the monitoring and modelling of stroke have led to more reliable estimates of stroke mortality and burden worldwide. However, little is known about the global distribution of stroke and its relations to the prevalence of cardiovascular disease risk factors and sociodemographic and economic characteristics. METHODS National estimates of stroke mortality and burden (measured in disability-adjusted life years [DALYs]) were calculated from monitoring vital statistics, a systematic review of studies that report disease surveillance, and modelling as part of the WHO Global Burden of Disease programme. Similar methods were used to generate standardised measures of the national prevalence of cardiovascular risk factors. Risk factors other than diabetes and disease burden estimates were age-adjusted and sex-adjusted to the WHO standard population. FINDINGS There was a ten-fold difference in rates of stroke mortality and DALY loss between the most-affected and the least-affected countries. Rates of stroke mortality and DALY loss were highest in eastern Europe, north Asia, central Africa, and the south Pacific. National per capita income was the strongest predictor of mortality and DALY loss rates (p<0.0001) even after adjustment for cardiovascular risk factors (p<0.0001). Prevalences of cardiovascular risk factors measured at a national level were generally poor predictors of national stroke mortality rates and burden, although raised mean systolic blood pressure (p=0.028) and low body-mass index (p=0.017) predicted stroke mortality, and greater prevalence of smoking predicted both stroke mortality (p=0.041) and DALY-loss rates (p=0.034). INTERPRETATION Rates of stroke mortality and burden vary greatly among countries, but low-income countries are the most affected. Current measures of the prevalence of cardiovascular risk factors at the population level poorly predict overall stroke mortality and burden and do not explain the greater burden in low-income countries.

[1]  J. Tuomilehto,et al.  Are Changes in Mortality From Stroke Caused by Changes in Stroke Event Rates or Case Fatality?: Results From the WHO MONICA Project , 2003, Stroke.

[2]  Alan D. Lopez,et al.  The Burden of Disease and Mortality by Condition: Data, Methods, and Results for 2001 -- Global Burden of Disease and Risk Factors , 2006 .

[3]  Alan D. Lopez,et al.  Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data , 2006, The Lancet.

[4]  M. Müllner,et al.  Influence of Socioeconomic Status on Mortality After Stroke: Retrospective Cohort Study , 2005, Stroke.

[5]  G. Gmel,et al.  Applying Principles of Comparative Risk Analysis to Substance Abuse-Related Burden , 2001, European Addiction Research.

[6]  Milton C Weinstein,et al.  Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis , 2006, The Lancet.

[7]  Majid Ezzati,et al.  Estimates of global and regional potential health gains from reducing multiple major risk factors , 2003, The Lancet.

[8]  Giuseppe Mancia,et al.  World Health Organization (WHO) and International Society of Hypertension (ISH) risk prediction charts: assessment of cardiovascular risk for prevention and control of cardiovascular disease in low and middle-income countries. , 2007, Journal of hypertension.

[9]  Maristela Monteiro,et al.  The Global Distribution of Average Volume of Alcohol Consumption and Patterns of Drinking , 2003, European Addiction Research.

[10]  J. Tu,et al.  Effect of Socioeconomic Status on Treatment and Mortality After Stroke , 2002, Stroke.

[11]  M. Brainin,et al.  Acute treatment and long-term management of stroke in developing countries , 2007, The Lancet Neurology.

[12]  P. Heuschmann,et al.  Standard method for developing stroke registers in low-income and middle-income countries: experiences from a feasibility study of a stepwise approach to stroke surveillance (STEPS Stroke) , 2007, The Lancet Neurology.

[13]  C. Mathers,et al.  Stroke incidence and prevalence in Europe: a review of available data , 2006, European journal of neurology.

[14]  T. Truelsen,et al.  Surveillance of stroke: a global perspective. , 2001, International journal of epidemiology.

[15]  Taghreed Adam,et al.  The burden and costs of chronic diseases in low-income and middle-income countries , 2007, The Lancet.

[16]  S. Wild,et al.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.

[17]  V. Feigin,et al.  Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review , 2009, The Lancet Neurology.

[18]  W. Rosamond,et al.  Income, Income Inequality, and Cardiovascular Disease Mortality: Relations Among County Populations of the United States, 1985 to 1994 , 2004, Southern medical journal.

[19]  Pravin K. Trivedi,et al.  Regression Analysis of Count Data , 1998 .

[20]  S. Yusuf,et al.  WHO study on Prevention of REcurrences of Myocardial Infarction and StrokE (WHO-PREMISE). , 2005, Bulletin of the World Health Organization.

[21]  S. Schwartz.  The fallacy of the ecological fallacy: the potential misuse of a concept and the consequences. , 1994, American journal of public health.

[22]  Ming Liu,et al.  Stroke in China: epidemiology, prevention, and management strategies , 2007, The Lancet Neurology.

[23]  C. Mathers,et al.  Preventing stroke: saving lives around the world , 2007, The Lancet Neurology.

[24]  S. Nishtar,et al.  Can non-physician health-care workers assess and manage cardiovascular risk in primary care? , 2007, Bulletin of the World Health Organization.

[25]  Alan D. Lopez,et al.  Global burden of disease and risk factors , 2006 .

[26]  B. Hedblad,et al.  Stroke Incidence, Recurrence, and Case-Fatality in Relation to Socioeconomic Position: A Population-Based Study of Middle-Aged Swedish Men and Women , 2008, Stroke.

[27]  R. Beaglehole,et al.  Stroke prevention in poor countries: time for action. , 2007, Stroke.

[28]  C. Mathers,et al.  Projections of Global Mortality and Burden of Disease from 2002 to 2030 , 2006, PLoS medicine.

[29]  J. Cuzick,et al.  A Wilcoxon-type test for trend. , 1985, Statistics in medicine.

[30]  J. Degaute,et al.  Stroke prevention, treatment, and rehabilitation in sub-saharan Africa. , 2005, American journal of preventive medicine.

[31]  J Tuomilehto,et al.  International trends in mortality from stroke, 1968 to 1994. , 2000, Stroke.

[32]  Gelin Xu,et al.  The effect of socioeconomic status on three-year mortality after first-ever ischemic stroke in Nanjing, China , 2006, BMC public health.

[33]  C. Warlow,et al.  Burden of stroke in black populations in sub-Saharan Africa , 2007, The Lancet Neurology.

[34]  G. E. Who,et al.  Preventing chronic diseases: a vital investment , 2005 .

[35]  S. Yusuf,et al.  Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. , 2001, Circulation.

[36]  Jan J Barendregt,et al.  A generic model for the assessment of disease epidemiology: the computational basis of DisMod II , 2003, Population health metrics.

[37]  C. Murray,et al.  Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment , 2006, The Lancet.

[38]  N L Greengold,et al.  Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Association. , 1999, JAMA.

[39]  A. Rodgers,et al.  Global burden of blood-pressure-related disease, 2001 , 2008, The Lancet.

[40]  V. Feigin,et al.  Stroke in developing countries: can the epidemic be stopped and outcomes improved? , 2007, The Lancet Neurology.